Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 12 - Number 1
Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery
, 12(1): 1 - 13G. Kauselmann, A. Dopazo and W. Link
DOI: 10.2174/156800912798888947
Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
, 12(1): 14 - 22H. Miyamoto, Y. Zheng and K. Izumi
DOI: 10.2174/156800912798888965
The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
, 12(1): 23 - 43A. Amini, S. Masoumi Moghaddam, D. L. Morris and M. H. Pourgholami
DOI: 10.2174/156800912798888956
Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations
, 12(1): 44 - 50C. F. Singer, P. Zabkova, C. Rappaport, D. Muhr, G. Pfeiler, D. Gschwantler-Kaulich, A. Fink-Retter, C. Staudigl, I. Walter, G. Hudelist, A.-C. Spiess and E. Kubista
DOI: 10.2174/156800912798888938
The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells
, 12(1): 51 - 63H. Herrmann, M. Kneidinger, S. Cerny-Reiterer, T. Rulicke, M. Willmann, K. V. Gleixner, K. Blatt, G. Hormann, B. Peter, P. Samorapoompichit, W. Pickl, G. Y. Bharate, M. Mayerhofer, W. R. Sperr, H. Maeda and P. Valent
DOI: 10.2174/156800912798888992
Targeting Urokinase and the Transferrin Receptor with Novel, Anti-Mitotic N-Alkylisatin Cytotoxin Conjugates Causes Selective Cancer Cell Death and Reduces Tumor Growth
, 12(1): 64 - 73K. L. Vine, V. Indira Chandran, J. M. Locke, L. Matesic, J. Lee, D. Skropeta, J. B. Bremner and M. Ranson
DOI: 10.2174/156800912798888983
Knockdown of Insulin-Like Growth Factor I Receptor Inhibits the Growth and Enhances Chemo-Sensitivity of Liver Cancer Cells
, 12(1): 74 - 84Y.-W. Zhang, D.-L. Yan, W. Wang, H.-W. Zhao, X. Lu, J.-Z. Wu and J.-R. Zhou
DOI: 10.2174/156800912798888974
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net